Press Release
– Positive Full Results from Phase 1a Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Exceed Aclaris’ Target Profile, Validating Potential Best-in-Class Potency Advantage and Opportunity…
Study in a well-accepted mouse model of severe Tuberous Sclerosis Complex (TSC) showed that simufilam…
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), the company building…
Denver, Colorado, April 15, 2026 (GLOBE NEWSWIRE) — Apryse, a leader in document processing technology,…
VANCOUVER, British Columbia, April 15, 2026 (GLOBE NEWSWIRE) — General Fusion Inc. (“General Fusion” or…
LA VERGNE, Tenn., April 15, 2026 (GLOBE NEWSWIRE) — Take 5 Oil Change, a leading…
Somerset, New Jersey, USA – April 15, 2026 – Ardena, a specialist CDMO and bioanalytical…